Mercado Global de Biomarcadores Cardíacos | Tamaño de la Industria, Participación, Crecimiento, Informe, Análisis 2026-2035


Por Tipo de Biomarcador (Creatina Quinasa -MB (CK-MB), Troponinas (T e I), Mioglobina, Otros); Por indicación (Infarto de Miocardio, Insuficiencia Cardíaca Congestiva, Otros); Por Usuario Final (Hospitales, Clínicas Especializadas); Por Lugar de Prueba (Puntos de Atención, Pruebas de Laboratorio); Por Región (América del Norte, Europa, Asia Pacífico, América Latina y Medio Oriente y África); Dinámica del Mercado (2026-2035) y Panorama Competitivo

USD 12,47 Mil Millones

Tamaño del Mercado en 2025

9,90%

CAGR

USD 32,05 Mil Millones

Pronóstico del Mercado para 2035


Comprar Ahora

Tabla de Contenidos

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.


1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Industry Opportunities and Challenges  
8    Global Cardiac Biomarkers Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cardiac Biomarkers Historical Market (2019-2025) 
    8.3    Global Cardiac Biomarkers Market Forecast (2026-2035)
    8.4    Global Cardiac Biomarkers Market by Biomarker Type
        8.4.1    Creatine Kinase -MB (CK-MB)
            8.4.1.1    Historical Trend (2019-2025)
            8.4.1.2    Forecast Trend (2026-2035)
        8.4.2    Troponins (T and I)
            8.4.2.1    Historical Trend (2019-2025)
            8.4.2.2    Forecast Trend (2026-2035)
        8.4.3    Myoglobin
            8.4.3.1    Historical Trend (2019-2025)
            8.4.3.2    Forecast Trend (2026-2035)
        8.4.4    Brain Natriuretic Peptide (BNPs) or NT-proBNP
            8.4.4.1    Historical Trend (2019-2025)
            8.4.4.2    Forecast Trend (2026-2035)
        8.4.5    Ischemia Modified Albumin (IMA)
            8.4.5.1    Historical Trend (2019-2025)
            8.4.5.2    Forecast Trend (2026-2035)
        8.4.6    Others
    8.5    Global Cardiac Biomarkers Market by Indication
        8.5.1    Myocardial Infarction
            8.5.1.1    Historical Trend (2019-2025)
            8.5.1.2    Forecast Trend (2026-2035)
        8.5.2    Congestive Heart Failure
            8.5.2.1    Historical Trend (2019-2025)
            8.5.2.2    Forecast Trend (2026-2035)
        8.5.3    Acute Coronary Syndrome
            8.5.3.1    Historical Trend (2019-2025)
            8.5.3.2    Forecast Trend (2026-2035)
        8.5.4    Atherosclerosis
            8.5.4.1    Historical Trend (2019-2025)
            8.5.4.2    Forecast Trend (2026-2035)
        8.5.5    Others
    8.6    Global Cardiac Biomarkers Market by End User
        8.6.1    Hospitals
            8.6.1.1    Historical Trend (2019-2025)
            8.6.1.2    Forecast Trend (2026-2035)
        8.6.2    Speciality Clinics
            8.6.2.1    Historical Trend (2019-2025)
            8.6.2.2    Forecast Trend (2026-2035)
    8.7    Global Cardiac Biomarkers Market by Testing Location
        8.7.1    Point of Care
            8.7.1.1    Historical Trend (2019-2025)
            8.7.1.2    Forecast Trend (2026-2035)
        8.7.2    Laboratory Testing
            8.7.2.1    Historical Trend (2019-2025)
            8.7.2.2    Forecast Trend (2026-2035)
    8.8    Global Cardiac Biomarkers Market by Region
        8.8.1    North America
        8.8.2    Europe
        8.8.3    Asia Pacific
        8.8.4    Latin America
        8.8.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2019-2025)
        9.1.2    Forecast Trend (2026-2035)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2019-2025)
        9.2.2    Forecast Trend (2026-2035)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2019-2025)
        9.3.2    Forecast Trend (2026-2035)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2019-2025)
        9.4.2    Forecast Trend (2026-2035)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2019-2025)
        9.5.2    Forecast Trend (2026-2035)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    F. Hoffmann-La Roche Ltd
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Beckman Coulter, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Creative Diagnostics
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Bio-Rad Laboratories, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    bioMérieux SA
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Cardiac Biomarkers Market: Key Industry Highlights, 2019 and 2035
2.    Global Cardiac Biomarkers Historical Market: Breakup by Biomarker Type (USD Billion), 2019-2025
3.    Global Cardiac Biomarkers Market Forecast: Breakup by Biomarker Type (USD Billion), 2026-2035
4.    Global Cardiac Biomarkers Historical Market: Breakup by Indication (USD Billion), 2019-2025
5.    Global Cardiac Biomarkers Market Forecast: Breakup by Indication (USD Billion), 2026-2035
6.    Global Cardiac Biomarkers Historical Market: Breakup by End-User (USD Billion), 2019-2025
7.    Global Cardiac Biomarkers Market Forecast: Breakup by End-User (USD Billion), 2026-2035
8.    Global Cardiac Biomarkers Historical Market: Breakup by Testing Location (USD Billion), 2019-2025
9.    Global Cardiac Biomarkers Market Forecast: Breakup by Testing Location (USD Billion), 2026-2035
10.    Global Cardiac Biomarkers Historical Market: Breakup by Region (USD Billion), 2019-2025
11.    Global Cardiac Biomarkers Market Forecast: Breakup by Region (USD Billion), 2026-2035
12.    North America Cardiac Biomarkers Historical Market: Breakup by Country (USD Billion), 2019-2025
13.    North America Cardiac Biomarkers Market Forecast: Breakup by Country (USD Billion), 2026-2035
14.    Europe Cardiac Biomarkers Historical Market: Breakup by Country (USD Billion), 2019-2025
15.    Europe Cardiac Biomarkers Market Forecast: Breakup by Country (USD Billion), 2026-2035
16.    Asia Pacific Cardiac Biomarkers Historical Market: Breakup by Country (USD Billion), 2019-2025
17.    Asia Pacific Cardiac Biomarkers Market Forecast: Breakup by Country (USD Billion), 2026-2035
18.    Latin America Cardiac Biomarkers Historical Market: Breakup by Country (USD Billion), 2019-2025
19.    Latin America Cardiac Biomarkers Market Forecast: Breakup by Country (USD Billion), 2026-2035
20.    Middle East and Africa Cardiac Biomarkers Historical Market: Breakup by Country (USD Billion), 2019-2025
21.    Middle East and Africa Cardiac Biomarkers Market Forecast: Breakup by Country (USD Billion), 2026-2035
22.    Global Cardiac Biomarkers Market Structure.

Contenidos